Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.20.2
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 64,370 $ 4,960
Marketable securities 137,990 112,904
Investment in equity securities 78,872  
Accounts receivable (including amounts from related parties of $0 and $1,050 as of September 30, 2020 and December 31, 2019, respectively) 7,483 6,298
Prepaid expenses and other current assets 3,583 4,406
Total current assets 292,298 128,568
Property and equipment, net 11,945 9,633
Marketable securities, non-current 0 15,609
Other non-current assets 2,122 2,545
Restricted cash 872 15
Total assets 307,237 156,370
Current liabilities:    
Accounts payable 4,879 5,584
Accrued compensation 5,890 6,017
Deferred revenue—current 15,703 19,465
Debt—current   1,000
Other current liabilities 3,438 901
Total current liabilities 29,910 32,967
Deferred revenue, non-current 8,366 16,195
Deferred rent 280 409
Debt—non-current 24,411 8,876
Other noncurrent liabilities 151 134
Total liabilities 63,118 58,581
Stockholders’ equity:    
Preferred stock, $0.001 par value — 10,000,000 shares authorized as of September 30, 2020 and December 31, 2019; 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019
Common stock, $0.001 par value — 300,000,000 shares authorized as of September 30, 2020 and December 31, 2019; 38,092,978 and 23,098,969 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 38 23
Additional paid-in-capital 412,173 293,346
Accumulated other comprehensive income 237 165
Accumulated deficit (168,329) (195,745)
Total stockholders’ equity 244,119 97,789
Total Liabilities and Stockholders’ Equity $ 307,237 $ 156,370